Dual targeting of insulin and venus kinase Receptors of Schistosoma mansoni for novel anti-schistosome therapy.

Por Mathieu Vanderstraete, Nadège Gouignard, Katia Cailliau, Marion Morel, Julien Lancelot, Jean-François Bodart, Colette Dissous
Publicado em 2013-01-01

Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth

Por Ming Jang Chua, Megan S.J. Arnold, Weijun Xu, Julien Lancelot, Suzanne Lamotte, Gerald F. Späth, Eric Prina, Raymond J. Pierce, David P. Fairlie, Tina S. Skinner-Adams, Katherine T. Andrews
Publicado em 2017-04-01